Prize contingency management for smoking cessation: a randomized trial.
David M Ledgerwood1, Cynthia L Arfken1, Nancy M Petry2
1Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Drive, Detroit, MI 48201, USA.
Drug and Alcohol Dependence
|May 6, 2014
Summary
Prize-based contingency management (CM) significantly reduced smoking during treatment compared to standard care. However, these smoking cessation benefits did not last long-term.
Area of Science:
- Behavioral Science
- Addiction Medicine
- Public Health
Background:
- Adjunctive behavioral treatments can enhance smoking cessation outcomes.
- Standard care (SC) for smoking cessation involves brief counseling and monitoring.
- Prize-based contingency management (CM) offers incentives for verified smoking abstinence.
Purpose of the Study:
- To compare standard care (SC) with SC plus prize-based contingency management (CM).
- To evaluate two prize reinforcement schedules: traditional CM and early enhanced CM.
- To assess the efficacy of CM in improving smoking cessation rates.
Main Methods:
- Eighty-one nicotine-dependent smokers were randomly assigned to three conditions.
- One group received SC; another received SC plus traditional CM.
- The third group received SC plus early enhanced CM, with greater initial reinforcement.
Main Results:
- Prize CM significantly reduced smoking during the treatment period compared to SC.
- No significant long-term reductions in smoking were observed at follow-up.
- No meaningful differences were found between traditional and early enhanced CM schedules.
Conclusions:
- Prize-based CM effectively reduces smoking during treatment compared to standard care.
- The positive effects of CM on smoking cessation did not extend beyond the treatment phase.
- Both traditional and enhanced CM schedules demonstrated similar efficacy.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K


